Photo from wikipedia
Monotherapy with pegylated interferon‐α (Peg‐IFNα) or the nucleos(t)ide analogs (NA) currently approved for treating chronic hepatitis B (CHB) has limited efficacy. Studies on the combination of Peg‐IFNα/NA have shown conflicting… Click to show full abstract
Monotherapy with pegylated interferon‐α (Peg‐IFNα) or the nucleos(t)ide analogs (NA) currently approved for treating chronic hepatitis B (CHB) has limited efficacy. Studies on the combination of Peg‐IFNα/NA have shown conflicting results. We investigated whether sequentially adding on Peg‐IFNα to tenofovir enhances serological response rates.
Keywords:
chronic hepatitis;
hepatitis;
pegylated interferon;
efficacy;
monotherapy;
peg ifn
Journal Title: Hepatology Research
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Hepatology Research
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!